source: American College of Gastroenterology
Bernard Levin, David A. Lieberman, Beth McFarland, Robert A. Smith, Durado Brooks, Kimberly S. Andrews, Chiranjeev Dash, Francis M. Giardiello, Seth Glick, Theodore R. Levin, Perry Pickhardt, Douglas K. Rex, Alan Thorson, Sidney J. Winawer
In the United States, colorectal cancer (CRC) is the third most common cancer diagnosed among men and women and the second leading cause of death from cancer. CRC largely can be prevented by the detection and removal of adenomatous polyps, and survival is significantly better when CRC is diagnosed while still localized. In 2006 to 2007, the American Cancer Society, the US Multi Society Task Force on Colorectal Cancer, and the American College of Radiology came together to develop consensus guidelines for the detection of adenomatous polyps and CRC in asymptomatic average-risk adults. In this update of each organization’s guidelines, screening tests are grouped into those that primarily detect cancer early and those that can detect cancer early and also can detect adenomatous polyps, thus providing a greater potential for prevention through polypectomy. When possible, clinicians should make patients aware of the full range of screening options, but at a minimum they should be prepared to offer patients a choice between a screening test that is effective at both early cancer detection and cancer prevention through the detection and removal of polyps and a screening test that primarily is effective at early cancer detection. It is the strong opinion of these 3 organizations that colon cancer prevention should be the primary goal of screening.
American Cancer Society, The American Gastroenterology Association, The Radiological Society of North America